BIOCON Charts, Analysis and Tips

home > pharma-and-healthcare > pharmaceuticals > biocon

Technical Analysis

Technical Strength: 2.1 / 10
Indicator Analysis Signal (0 - 10) Chart
RSI (?) RSI is 41.3. According to RSI analysis, biocon is weak. 3.0 BIOCON RSI Chart
MACD (?) MACD: -1.24 and Signal Line: -0.837. According to MACD analysis, a bearish crossover just happend and it's a negative signal. 2.0 BIOCON MACD Chart
Simple Moving Average (?) According to simple moving average analysis, biocon is in a downtrend. Resistance level is at 332. 1.0 BIOCON Simple Moving Average Chart
Exponential Moving Average (?) Price just got below it's 200-day exponential moving average which is a negative signal. According to exponential moving average analysis, biocon is in a downtrend. Resistance level is at 323. 0.0 BIOCON Exponential Moving Average Chart
Bollinger Bands (?) %b is 0.249. According to bollinger bands, biocon is technically weak. 3.0 BIOCON Bollinger Bands Chart
Fibonacci Retracement (?) According to fibonacci retracement, price is below all levels. Resistance levels are 333.6026 and 345.516666667. Support level is 295.033333333. 2.5 BIOCON Fibonacci Retracement Chart
Average True Range (?) ATR: 10.3 NA BIOCON Average True Range Chart
Average Directional Index (?) ADX is 16.6 which means BIOCON is in a trading range and there is no trend. NA BIOCON Average Directional Index Chart
Note: Technical Analysis updated at 7PM on every trading day.
End-of-Day Share Price - NSE
June 27, 2017
Open Price 327.0
High Price 332.9
Low Price 319.9
Close Price 322.95
Absolute Change -5.95
Percentage Change -1.81%
Weekly Change -2.23%
Monthly Change 2.42%
Yearly Change 33.4%
52-week high 396.0
52-week low 229.383333333
Corporate Actions
ExDate Purpose
July 20, 2017 AGM/DIV-RE 1 PER SHARE
June 15, 2017 BONUS 2:1
June 22, 2016 ANNUAL GENERAL MEETING
See all Corporate Actions
Volume Chart
Real time prices can be delayed by 20 minutes. Prices are refreshed from our server automatically after 1 minute. If NSE real time price is not available then BSE real time prices are provided. Volume displayed might not be correct..

Fundamental Analysis

Beta (?)0.761
Confidence in Beta5.49%
Market Capital Rs. 6458.0 Cr
Diluted Trailing Twelve Months (TTM) Earnings Per Share (EPS) Rs. 14.5566666667
TTM Price-to-Earnings (P/E) Ratio 22.2
Whenever available, consolidated financial results are used. For details, see here.
Stock Deliverable Quantity and Daily Volatility
Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
Deliverable Quantity (?) 27 June 2017: Deliverable Quantity:6.08e+05 NA BIOCON Deliverable Quantity Chart
Annualized Daily Volatility (Spot Price) (?) 27 June 2017: Daily Volatility:0.363 NA BIOCON Annualized Daily Volatility (Spot Price) Chart

Futures & Options Analysis

Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
PCR (?) 27 June 2017: PCR_OI:0.743 PCR:0.242 NA BIOCON PCR Chart
Premium (?) 27 June 2017 Premium: 1.3 Futures OI:6471000.0 NA BIOCON Premium Chart
Option_MAX_OI (?) 27 June 2017: Price:322.95 Put with maximum OI:330.0 Call with maximum OI:353.35 NA BIOCON Option_MAX_OI Chart

Futures - NSE

Expiry Date Close Price Open Interest Number of Trades No of Contracts Underlying Closing Price
June 29, 2017 324.25 6471000.0 1838.0 2836.0 322.95
July 27, 2017 324.45 5700600.0 930.0 1831.0 322.95
August 31, 2017 325.8 28800.0 8.0 8.0 322.95

Announcements

June 23, 2017 BiocAnalysts/Institutional Investor Meet/Con. Call Updatescon Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates
June 22, 2017 BiocAGM/Book Closurecon Limited has informed the Exchange that the Register of Members and Share Transfer Books of the Company shall remain closed from July 22, 2017 to July 28, 2017(both days inclusive) for the purpose of Annual General Meeting of the Company is scheduled to be held on July 28, 2017 & Dividend
See all Announcements

Board Meetings

Date Meeting Date Purpose
April 25, 2017 April 27, 2017 The Results/Dividend/Bonus Company had informed the Exchange regarding the meeting of the Board of Directors of the Company scheduled to be held on April 27, 2017 inter alia, to consider, approve and take on record, the audited financial results (both standalone and consolidated) of the Company for the year ended March 31, 2017 amongst other routine matters recommendation of final dividend , if any , for the financial year 2016-17. The Company has now informed the Exchange that the board to consider and recommend to issue bonus share.(purpose revised).
April 20, 2017 April 27, 2017 The Results/Dividend Company had informed the Exchange regarding the meeting of the Board of Directors of the Company scheduled to be held on April 27, 2017 inter alia, to consider, approve and take on record, the audited financial results (both standalone and consolidated) of the Company for the year ended March 31, 2017 amongst other routine matters. The Company has now informed the Exchange that the board also considered and recommendation of final dividend , if any , for the financial year 2016-17.(purpose revised).
See all Board Meetings

BIOCON is part of...

Index Weightage
NFTYMCAP50 NA

Intraday Pivot Points

S3 S2 S1 Pivot R1 R2 R3
Rs. 304.6 Rs. 312.2 Rs. 317.6 Rs. 325.2 Rs. 330.6 Rs. 338.2 Rs. 343.6